Solar abundances and 3D model atmospheres
- 期刊名称Proceedings of the International Astronomical Union
- 作者Ludwig, Hans-Günter; Caffau, Elisabetta; Steffen, Matthias; Bonifacio, Piercarlo; Freytag, Bernd; Cayrel, Roger
- 卷第5卷
- 印刷ISSN1743-9213
- 电子ISSN1743-9221
- 文件大小259.33KB
- 发表时间2009-8
- DOI10.1017/s1743921310000542
Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR InhibitorsHeigener, D. F.; Schumann, C.; Sebastian, M.; Sadjadian, P.; Stehle, I.; Marten, A.; Luers, A.; Griesinger, F.; Scheffler, M. · The Oncologist · 2015
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer harboring uncommon EGFR mutations: Focus on afatinibMasood, Ashiq; Kancha, Rama Krishna; Subramanian, Janakiraman · Seminars in Oncology · 2019
Case report: Durable response to afatinib in a patient with lung cancer harboring two uncommon mutations of EGFR and a KRAS mutationTanizaki, Junko; Banno, Eri; Togashi, Yosuke; Hayashi, Hidetoshi; Sakai, Kazuko; Takeda, Masayuki; Kaneda, Hiroyasu; Nishio, Kazuto; Nakagawa, Kazuhiko · Lung Cancer · 2016
Afatinib administration in a patient with non-small cell lung cancer harboring uncommon EGFR mutation G719A undergoing hemodialysisYamaguchi, Teppei; Hayashi, Hideki; Isogai, Sumito; Hayashi, Masamichi; Uozu, Sakurako; Goto, Yasuhiro; Nakanishi, Toru; Sugiyama, Tadashi; Itoh, Yoshinori; Imaizumi, Kazuyoshi · Cancer Treatment Communications · 2015
Cost-Utility Analysis of First-Line Gefitinib, Erlotinib and Afatinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR MutationsHolleman, MS; Zaim, R; Uyl-De Groot, CA · Value in Health · 2016
P1.14-30 Phase I Study of Afatinib Plus Bevacizumab in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR MutationsTokito, T.; Ko, R.; Imamura, C.; Shukuya, T.; Shimada, N.; Koyama, R.; Yamada, K.; Ishii, H.; Azuma, K.; Takahashi, K. · Journal of Thoracic Oncology · 2019
Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non-small cell lung cancer harboring activating <i>EGFR</i> mutations: Subgroup analysis of LUX-Lung 3Kato, Terufumi; Yoshioka, Hiroshige; Okamoto, Isamu; Yokoyama, Akira; Hida, Toyoaki; Seto, Takashi; Kiura, Katsuyuki; Massey, Dan; Seki, Yoko; Yamamoto, Nobuyuki · Cancer Science · 2015
The association between baseline clinical–radiological characteristics and growth of pulmonary nodules with ground-glass opacityKobayashi, Yoshihisa; Sakao, Yukinori; Deshpande, Gautam A.; Fukui, Takayuki; Mizuno, Tetsuya; Kuroda, Hiroaki; Sakakura, Noriaki; Usami, Noriyasu; Yatabe, Yasushi; Mitsudomi, Tetsuya · Lung Cancer · 2014
Recent evidence, advances, and current practices in surgical treatment of lung cancerSuda, Kenichi; Sato, Katsuaki; Mizuuchi, Hiroshi; Kobayashi, Yoshihisa; Shimoji, Masaki; Tomizawa, Kenji; Takemoto, Toshiki; Iwasaki, Takuya; Sakaguchi, Masahiro; Mitsudomi, Tetsuya · Respiratory Investigation · 2014
How Long Should Small Lung Lesions of Ground-Glass Opacity be Followed?Kobayashi, Yoshihisa; Fukui, Takayuki; Ito, Simon; Usami, Noriyasu; Hatooka, Shunzo; Yatabe, Yasushi; Mitsudomi, Tetsuya · Journal of Thoracic Oncology · 2013
Prognostic impact of pleural lavage cytology in patients with primary lung cancerTomizawa, Kenji; Nishino, Masaya; Sesumi, Yuichi; Kobayashi, Yoshihisa; Sato, Katsuaki; Chiba, Masato; Shimoji, Masaki; Suda, Kenichi; Shimizu, Shigeki; Sato, Takao; Takemoto, Toshiki; Mitsudomi, Tetsuya · Lung Cancer · 2016
Clinicoradiologic characteristics of patients with lung adenocarcinoma harboring EML4-ALK fusion oncogeneFukui, Takayuki; Yatabe, Yasushi; Kobayashi, Yoshihisa; Tomizawa, Kenji; Ito, Simon; Hatooka, Shunzo; Matsuo, Keitaro; Mitsudomi, Tetsuya · Lung Cancer · 2012
Clinical and pathologic features of lung cancer expressing programmed cell death ligand 1 (PD-L1)Shimoji, Masaki; Shimizu, Shigeki; Sato, Katsuaki; Suda, Kenichi; Kobayashi, Yoshihisa; Tomizawa, Kenji; Takemoto, Toshiki; Mitsudomi, Tetsuya · Lung Cancer · 2016
Dual blockade of EGFR tyrosine kinase using osimertinib and afatinib eradicates EGFR‑mutant Ba/F3 cellsYonesaka, Kimio; Kobayashi, Yoshihisa; Hayashi, Hidetoshi; Chiba, Yasutaka; Mitsudomi, Tetsuya; Nakagawa, Kazuhiko · Oncology Reports · 2018
Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategyKobayashi, Yoshihisa; Mitsudomi, Tetsuya · Cancer Science · 2016
Spotlight on circulating tumour cellsBlackhall, Fiona; Dive, Caroline · Translational Lung Cancer Research · 2017
Methylation analyses in liquid biopsyLissa, Delphine; Robles, Ana I. · Translational Lung Cancer Research · 2016
Ki-67 expression in pulmonary tumorsChirieac, Lucian R. · Translational Lung Cancer Research · 2016
Commentary on tumor heterogeneityPopper, Helmut H. · Translational Lung Cancer Research · 2016
Editorial on PanCan studyMarshall, Henry M.; Yang, Ian A.; Bowman, Rayleen V.; Fong, Kwun M. · Translational Lung Cancer Research · 2018
Editorial commentary: meeting a paramount challengeYang, Ping · Translational Lung Cancer Research · 2018
Rebuttal from Prof. RodriguesRodrigues, George · Translational Lung Cancer Research · 2016
Rebuttal from Professor Sanja DacicDacic, Sanja · Translational Lung Cancer Research · 2007